Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthma
Author:
Funder
The University of Chicago
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference41 articles.
1. Beyond type 2 cytokines in asthma—new insights from old clinical trials;Choy;Expert Opin Ther Targets,2020
2. The cytokines of asthma;Lambrecht;Immunity,2019
3. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials;Hanania;Lancet Respir Med,2016
4. Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies;Hanania;Thorax,2015
5. Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma;Albers;Respir Med,2019
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The host protease KLK5 primes and activates spike proteins to promote human betacoronavirus replication and lung inflammation;Science Signaling;2024-08-20
2. Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies;European Respiratory Journal;2024-05-02
3. Comparative analyses of Netherton syndrome patients and Spink5 conditional knock-out mice uncover disease-relevant pathways;Communications Biology;2024-02-05
4. Genomics of Treatable Traits in Asthma;Genes;2023-09-20
5. Αnti-KLK5/KLK7 Antibody-based Strategies for the Treatment of Epidermal Diseases;Current Pharmaceutical Design;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3